British Airways Pensions Investment Management’s Edwards Lifesciences EW Stock Holding History

British Airways Pensions Investment Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-668,181	Closed	-$20.9M	–	122
2016 Q4	$20.9M	Sell	668,181 -51,171	-7%	-$1.66M	0.6%	81
2016 Q3	$28.9M	Sell	719,352 -648	-0.1%	-$24.4K	0.85%	54
2016 Q2	$24M	Hold	720,000	–	–	0.72%	64
2016 Q1	$21.2M	Buy	+720,000	New	+$19.9M	0.66%	67

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

British Airways Pensions Investment Management's EW Position: Q1 2017 in Review

British Airways Pensions Investment Management sold out of Edwards Lifesciences (EW) in Q1 2017, closing a stake of 668,181 shares — an estimated $20.9M sold.

British Airways Pensions Investment Management first reported a position in EW in Q1 2016 and held it in 4 quarters. The position peaked at $28.9M in Q3 2016. 691 funds tracked by Wall St. Rank hold EW as of Q1 2017.

British Airways Pensions Investment Management reported no remaining Edwards Lifesciences position as of Q1 2017 after selling out during the quarter.
British Airways Pensions Investment Management sold 668,181 Edwards Lifesciences shares in Q1 2017, an estimated $20.9M.
British Airways Pensions Investment Management first reported a position in Edwards Lifesciences in Q1 2016 and held it in 4 quarters.
British Airways Pensions Investment Management's Edwards Lifesciences position peaked at $28.9M in Q3 2016.
691 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2017.

Based on British Airways Pensions Investment Management's 13F filing for Q1 2017, filed 2 May 2017.